REAL-WORLD OVERALL SURVIVAL OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: RESULTS OF A CLAIMS DATA STUDY OF PATIENTS IN GERMANY

被引：0
|
作者：
Gottschalk, F. [1 ]
Cizova, D. [1 ]
Mueller, S. [1 ]
Myers, D. [2 ]
Wilke, T. [3 ]
Maywald, U. [4 ]
机构：
[1] Inst Pharmakookon & Arzneimittellogist IPAM eV, Wismar, Germany
[2] Johnson & Johnson, Janssen Pharmaceut Co, Stockholm, Sweden
[3] IPAM Inst Pharmakookon & Arzneimittellogist eV, Wismar, Germany
[4] AOK Plus Gesundheitskasse Sachsen & Thuringen, Dresden, Germany
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.142
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN60
引用
收藏
页码：S24 / S24
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: RESULTS OF A CLAIMS DATA STUDY OF PATIENTS IN GERMANY
    Cizova, D.
    Gottschalk, F.
    Mueller, S.
    Myers, D.
    Wilke, T.
    [J]. VALUE IN HEALTH, 2018, 21 : S22 - S22
  • [2] REAL-WORLD PROGRESSION- FREE SURVIVAL OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: RESULTS OF A CLAIMS DATA STUDY OF PATIENTS IN GERMANY
    Cizova, D.
    Gottschalk, F.
    Mueller, S.
    Myers, D.
    Wilke, T.
    [J]. VALUE IN HEALTH, 2018, 21 : S24 - S24
  • [3] REAL WORLD TREATMENT AND SURVIVAL OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER: AN ANALYSIS USING JAPANESE CLAIMS DATA
    Ghiani, M.
    Bruellinger, L.
    Mueller, S.
    Wilke, T.
    [J]. VALUE IN HEALTH, 2019, 22 : S534 - S534
  • [4] Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
    Hardtstock, Fraence
    Myers, David
    Li, Tracy
    Cizova, Diana
    Maywald, Ulf
    Wilke, Thomas
    Griesinger, Frank
    [J]. BMC CANCER, 2020, 20 (01)
  • [5] Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
    Fränce Hardtstock
    David Myers
    Tracy Li
    Diana Cizova
    Ulf Maywald
    Thomas Wilke
    Frank Griesinger
    [J]. BMC Cancer, 20
  • [6] Immunotherapy in Hispanic patients with advanced non-small cell lung cancer: A real-world data.
    Lujan, Mauricio
    Lema, Mauricio
    Preciado, Beatriz
    Lema, Camila
    Egurrola, Jorge
    Zorrilla, Andres Felipe Cardona
    Gonzalez, Diego Mauricio
    Mantilla, William Armando
    Pino, Luis
    Rojas, Gustavo
    Gomez-Abreo, Diego Andres
    Munevar, Isabel
    Manneh, Raimundo
    Kopp, Ray Manneh
    Lobaton, Jose F.
    Calle, Esteban
    Borras, Mariana
    Triana, Ivan Camilo
    Pineda, Mateo
    Ortio, Diego Moran
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhong, Qiuxia
    Liu, Zhihua
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4115 - 4128
  • [8] Impact of Comorbidity Scores on Overall Survival in Advanced Non-Small Cell Lung Cancer Patients -A Real-World Experience from Eastern India
    Mamidi, S. G.
    Mohapatra, P. R.
    Bhuniya, S.
    Majumdar, S. K. D.
    Mishra, P.
    Panigrahi, M. K.
    Bal, S. K.
    Datta, A.
    Venkatachalam, P.
    Chatterjee, D.
    Sarkar, S.
    Shirgaonkar, R. B.
    Girija, A.
    Ghosh, S.
    Padmaja, M. S.
    Acharyulu, V. R. M.
    Durgeshwar, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S496 - S496
  • [9] Impact of Comorbidity Scores on the Overall Survival of Patients With Advanced Non-small Cell Lung Cancer: A Real-World Experience From Eastern India
    Goud, M. Srikanth
    Mohapatra, Prasanta R.
    Bhuniya, Sourin
    Majumdar, Saroj Kumar Das
    Mishra, Pritinanda
    Panigrahi, Manoj K.
    Bal, Shakti K.
    Datta, Ananda
    Venkatachalam, Palanisamy
    Chatterjee, Debopam
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [10] Real-World Data Of Osimertinib In Patients With Pretreated Non-Small Cell Lung Cancer: A Retrospective Study
    Mu, Yuxin
    Xing, Puyuan
    Hao, Xuezhi
    Wang, Yan
    Li, Junling
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9243 - 9251
12345